Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Reports: Shein Files for Initial Public Offering
Online fashion retailer Sheen is reportedly said to go public. Multiple media outlets reported that the Chinese-founded company has filed confidentially for an initial public offering in the U.S.
Load More